Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN vs FOSTAMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN vs FOSTAMATINIB: Safety Overview

Metric FOSFOMYCIN FOSTAMATINIB
Total FAERS Reports 828 6,394
Deaths Reported 128 453
Death Rate 15.5% 7.1%
Hospitalizations 407 1,493
Average Patient Age 55.3 yrs 64.7 yrs
% Female Patients 57.3% 60.8%
FDA Approval Date Oct 22, 2025 Apr 17, 2018
Manufacturer Meitheal Pharmaceuticals Inc. Rigel Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription